Loading stock data…
Loading stock data…
US$184.44
Get one email when RVMD crosses your level. Checked every 15 minutes during market hours.
▼ -0.53 (-0.29%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
61.8
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
8.15
Bearish momentumMACD below its signal line (9.26).
50-day average
162.30
Price aboveShort-term trend reference.
200-day average
107.14
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Revolution Medicines Inc. is a clinical-stage precision oncology company focused on developing targeted cancer therapies. The company concentrates on inhibiting difficult-to-drug molecular targets within key cell growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways that are frequently altered in solid tumors. Its pipeline includes RMC-4630, a SHP2 inhibitor designed to disrupt signaling that supports tumor growth, as well as a portfolio of RAS(ON) inhibit…
www.revmed.com11 strong buy · 16 buy · 2 hold · 0 sell · 0 strong sell (29 analysts, 2026-07-01)
11 strong buy · 15 buy · 1 hold · 0 sell · 0 strong sell (27 analysts, 2026-06-01)
11 strong buy · 15 buy · 1 hold · 0 sell · 0 strong sell (27 analysts, 2026-05-01)
11 strong buy · 15 buy · 1 hold · 0 sell · 0 strong sell (27 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-29 | 0.74 | 0.92 | ✓ Beat |
| 2026-05-20 | 2.91 | 3.09 | ✓ Beat |
| 2026-05-06 | 2.55 | 2.72 | ✓ Beat |
| 2026-03-24 | -0.4 | -1 | ✗ Miss |
| 2026-02-25 | -1.56 | -1.86 | ✗ Miss |
| 2025-11-20 | 14.83 | 14.73 | ✗ Miss |
| 2025-11-05 | -1.41 | -1.61 | ✗ Miss |
Companies in the same industry, via Finnhub